Navigation Links
US, Kazakhstan to share standards for quality of medicines
Date:10/25/2010

Rockville, Md., October 25, 2010 With the mutual goal of improving the quality of pharmaceuticals worldwide, the United States Pharmacopeial Convention (USP) and the Republican State Enterprise (RSE) National Centre for Expertise of Drugs, Medical Products and Equipment ("the Centre") of the Ministry of Health of the Republic of Kazakhstan have entered into an agreement to share standards for the quality, purity, strength and identity of medicines. Specifically, the Centre will have a five-year renewable right to include written standards from the United States PharmacopeiaNational Formulary (USPNF) in the State Pharmacopoeia of the Republic of Kazakhstan. The standards may either be included entirely as they are published in the USPNF, in translation ("adopted") or modified to better suit the Centre's requirements for Kazakhstan ("adapted").

The agreement was signed by Dr. Roger L. Williams, USP's chief executive officer, and Dr. Larissa Pak, deputy chair, Committee on Surveillance of Medical and Pharmaceutical Activities of the Ministry of Health of the Republic of Kazakhstan, today at the RSE in Almaty, Kazakhstan.

According to USP's Dr. Williams, "Promoting public health internationally is an important goal for the Centre and for USP. The scientific exchange represented by this agreement will serve to benefit the citizens and manufacturers of Kazakhstan. USP will benefit from the experience of the Centre's scientists, which in turn contributes to the strength and relevance of the standards published in the USPNF."

Dr. Pak concurred: "Collaboration activities among national pharmacopeias serve to benefit public health on an international scale. As pharmaceuticals continue to be sourced and distributed across international borders, scientific exchange will play an increasingly important role in ensuring the quality of medicines worldwide." Beyond the use of USPNF written, documentary standards, the Centre will explore opportunities to use USP's accompanying reference standards, which are physical or chemical "yardsticks" by which pharmaceutical manufacturers and regulators measure the quality and identity of medicines. Officials from USP and the Centre have held several high-level meetings over the past year exploring opportunities for cooperation, culminating in this new agreement.


'/>"/>

Contact: Francine Pierson
fp@usp.org
301-816-8588
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. MyDietShopz.com Announces Biggest Losers Contest - Share Your Story To Inspire Others
2. SHARECOR Partners With Quantros, Inc. to Facilitate Core Measures and Regulatory Reporting in Louisiana Hospitals
3. The Ensign Group Reports Fourth Quarter 2009 Adjusted Earnings of $0.43 Per Share; Issues 2010 Guidance
4. Tyco International to Host 2010 Annual General Meeting of Shareholders
5. Check City Announces New Payday Affiliate Campaign Through Partnership With The Share A Sale Affiliate Network
6. Doctors Share Longevity Secrets on CBS Broadcasts
7. Micromet Announces Pricing of Public Offering of 10 Million Shares of Common Stock
8. Mission Pharmacal and March of Dimes Share Commitment to Healthy Babies
9. Golden Meditech Shareholders Approves of Name Change
10. Media Alert: Model N and International Medical Device Leader to Share Insights on Maximizing Sales Performance with Revenue Management
11. New Social Media Site Launches Movement To Inspire The World! eStoryShare.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... ... tooth replacement options at his office, Antoine Dental Center. Currently, patients can get ... Some restrictions may apply, but patients can learn more about these offers by ...
(Date:2/24/2017)... ... , ... An in-depth computational analysis of genetic variants implicated in both schizophrenia ... that may explain why susceptibility to one of the disorders could place individuals at ... in the journal npj Schizophrenia. , “There is a wealth of genomic data ...
(Date:2/24/2017)... NY (PRWEB) , ... February 24, 2017 , ... In ... needs to be a top priority because it’s not if you will be attacked, ... safety, especially when it comes to digital health care. , Improvements in auditing and ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: An Australian ... account of his paramedic experiences. Schanssema describes the tragedies he saw, as well as ... overcome them. , Schanssema, initially unsure of the career path he wanted to take, ...
(Date:2/24/2017)... , ... February 24, 2017 , ... Yisrayl Hawkins, Pastor ... on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement when ... generation. He explains that the Bible details the current times so plainly that ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 Report analyzes the worldwide ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... are provided for the period 2015 through 2022. Also, a ... and analytics are derived from primary and secondary research. Company ...
(Date:2/24/2017)... , Feb. 23, 2017  This report analyzes ... by the following Products: Intermediates, Analytical, ... the report include Pharmaceuticals, and Agrochemicals. The report provides ... , Europe , and Rest ... the period 2015 through 2022. Also, a six-year historic ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
Breaking Medicine Technology: